Senescence and cancer—role and therapeutic opportunities
Cellular senescence is a state of stable, terminal cell cycle arrest associated with various
macromolecular changes and a hypersecretory, pro-inflammatory phenotype. Entry of cells …
macromolecular changes and a hypersecretory, pro-inflammatory phenotype. Entry of cells …
Targeting p53 pathways: mechanisms, structures, and advances in therapy
The TP53 tumor suppressor is the most frequently altered gene in human cancers, and has
been a major focus of oncology research. The p53 protein is a transcription factor that can …
been a major focus of oncology research. The p53 protein is a transcription factor that can …
[HTML][HTML] Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting
LJH Borrero, WS El-Deiry - Biochimica et Biophysica Acta (BBA)-Reviews …, 2021 - Elsevier
TP53 is the most commonly mutated gene in human cancer with over 100,000 literature
citations in PubMed. This is a heavily studied pathway in cancer biology and oncology with a …
citations in PubMed. This is a heavily studied pathway in cancer biology and oncology with a …
Targeting p53–MDM2 interaction by small-molecule inhibitors: Learning from MDM2 inhibitors in clinical trials
H Zhu, H Gao, Y Ji, Q Zhou, Z Du, L Tian… - Journal of hematology & …, 2022 - Springer
Abstract p53, encoded by the tumor suppressor gene TP53, is one of the most important
tumor suppressor factors in vivo and can be negatively regulated by MDM2 through p53 …
tumor suppressor factors in vivo and can be negatively regulated by MDM2 through p53 …
p53: 800 million years of evolution and 40 years of discovery
AJ Levine - Nature Reviews Cancer, 2020 - nature.com
The evolutionarily conserved p53 protein and its cellular pathways mediate tumour
suppression through an informed, regulated and integrated set of responses to …
suppression through an informed, regulated and integrated set of responses to …
Mutant p53: it's not all one and the same
MC Kennedy, SW Lowe - Cell Death & Differentiation, 2022 - nature.com
Mutation of the TP53 tumor suppressor gene is the most common genetic alteration in
cancer, and almost 1000 alleles have been identified in human tumors. While virtually all …
cancer, and almost 1000 alleles have been identified in human tumors. While virtually all …
Putting p53 in context
ER Kastenhuber, SW Lowe - Cell, 2017 - cell.com
TP53 is the most frequently mutated gene in human cancer. Functionally, p53 is activated by
a host of stress stimuli and, in turn, governs an exquisitely complex anti-proliferative …
a host of stress stimuli and, in turn, governs an exquisitely complex anti-proliferative …
The p53 network: cellular and systemic DNA damage responses in cancer and aging
PL Vaddavalli, B Schumacher - Trends in Genetics, 2022 - cell.com
The tumor protein TP53 gene, encoding the cellular tumor antigen p53, is the single most
frequently mutated gene in human cancers. p53 plays a central role in responding to DNA …
frequently mutated gene in human cancers. p53 plays a central role in responding to DNA …
[HTML][HTML] Senescence in health and disease
S He, NE Sharpless - Cell, 2017 - cell.com
Many cellular stresses activate senescence, a persistent hyporeplicative state characterized
in part by expression of the p16 INK4a cell-cycle inhibitor. Senescent cell production occurs …
in part by expression of the p16 INK4a cell-cycle inhibitor. Senescent cell production occurs …
Targeting mutant p53 for efficient cancer therapy
VJN Bykov, SE Eriksson, J Bianchi… - Nature Reviews Cancer, 2018 - nature.com
The tumour suppressor gene TP53 is the most frequently mutated gene in cancer. Wild-type
p53 can suppress tumour development by multiple pathways. However, mutation of TP53 …
p53 can suppress tumour development by multiple pathways. However, mutation of TP53 …